CytomX Therapeutics Inc (CTMX)
0.9925
0.00 (0.00%)
USD |
NASDAQ |
Oct 31, 16:00
0.9948
0.00 (0.00%)
After-Hours: 20:00
CytomX Therapeutics Market Cap: 77.53M for Oct. 31, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 30, 2024 | 77.49M |
| October 29, 2024 | 78.04M |
| October 28, 2024 | 78.90M |
| October 25, 2024 | 80.46M |
| October 24, 2024 | 84.37M |
| October 23, 2024 | 84.37M |
| October 22, 2024 | 85.93M |
| October 21, 2024 | 90.62M |
| October 18, 2024 | 92.18M |
| October 17, 2024 | 90.62M |
| October 16, 2024 | 92.18M |
| October 15, 2024 | 87.49M |
| October 14, 2024 | 85.15M |
| October 11, 2024 | 89.84M |
| October 10, 2024 | 87.49M |
| October 09, 2024 | 89.84M |
| October 08, 2024 | 89.05M |
| October 07, 2024 | 91.40M |
| October 04, 2024 | 89.84M |
| October 03, 2024 | 88.27M |
| October 02, 2024 | 89.84M |
| October 01, 2024 | 89.84M |
| September 30, 2024 | 92.18M |
| September 27, 2024 | 93.74M |
| September 26, 2024 | 93.74M |
| Date | Value |
|---|---|
| September 25, 2024 | 91.40M |
| September 24, 2024 | 92.96M |
| September 23, 2024 | 89.84M |
| September 20, 2024 | 92.96M |
| September 19, 2024 | 91.40M |
| September 18, 2024 | 92.96M |
| September 17, 2024 | 94.52M |
| September 16, 2024 | 94.52M |
| September 13, 2024 | 96.08M |
| September 12, 2024 | 97.65M |
| September 11, 2024 | 102.33M |
| September 10, 2024 | 102.33M |
| September 09, 2024 | 97.65M |
| September 06, 2024 | 93.74M |
| September 05, 2024 | 92.18M |
| September 04, 2024 | 97.65M |
| September 03, 2024 | 87.49M |
| August 30, 2024 | 92.18M |
| August 29, 2024 | 89.84M |
| August 28, 2024 | 90.62M |
| August 27, 2024 | 92.96M |
| August 26, 2024 | 92.96M |
| August 23, 2024 | 94.52M |
| August 22, 2024 | 92.96M |
| August 21, 2024 | 99.21M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
71.55M
Minimum
Oct 27 2023
672.32M
Maximum
May 12 2020
238.17M
Average
180.13M
Median
Market Cap Benchmarks
| NovaBay Pharmaceuticals Inc | 3.620M |
| Palatin Technologies Inc | 24.34M |
| iBio Inc | 22.98M |
| Theriva Biologics Inc | 1.447M |
| Oragenics Inc | 1.674M |
Market Cap Related Metrics
| PE Ratio | 7.089 |
| PS Ratio | 0.6849 |
| Price | 0.9925 |
| Earnings Yield | 14.11% |
| Operating PE Ratio | 14.31 |
| Normalized PE Ratio | 7.089 |